Skip to content
2000
Volume 16, Issue 17
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome, whose pathogenesis begins with the accumulation of liver fat and is followed by the development of necro-inflammation and fibrosis. Recent evidence indicates that adipocytokines, polypeptides secreted by the adispose tissue, might play an important role in the pathogeneic process and progression of NAFLD. In this review, we explore the role of leptin, and in part of other adipocytokines, in the interference with hepatic injury associated with fatty infiltration, in the modulation of steatosis and fibrosis, in both experimental models of the disease and in the clinical practice. We also discuss the potential use of leptin as non-invasive marker for differentiating simple fatty liver from NAFLD, and the possible novel therapeutic strategies aimed at interfering with the leptin axis to dampen chronic liver inflammation and NAFLD.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161210791208884
2010-06-01
2025-06-16
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161210791208884
Loading

  • Article Type:
    Research Article
Keyword(s): adipocytokines; autoimmunity; leptin; liver; NAFLD
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test